A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis

被引：25

作者：

Brown, DS ^{[1
]}

Belfield, AJ ^{[1
]}

Brown, GR ^{[1
]}

Campbell, D ^{[1
]}

Foubister, A ^{[1
]}

Masters, DJ ^{[1
]}

Pike, KG ^{[1
]}

Snelson, WL ^{[1
]}

Wells, SL ^{[1
]}

机构：

[1] AstraZeneca, Macclesfield SK10 4TG, Cheshire, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 21期

关键词：

p38 MAP kinase inhibitors;

D O I：

10.1016/j.bmcl.2004.08.006

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A novel p38 MAP kinase inhibitor structural class was discovered through selectivity screening. The rational analogue design, synthesis and structure-activity relationship of this series of bisamide inhibitors is reported. The inhibition in vitro of human p38alpha enzyme activity and lipopolysaccharide-induced tumour necrosis factor-alpha release is described for the series. The activity in vivo and pharmacokinetic properties are exemplified for the more potent analogues. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：5383 / 5387

页数：5

共 50 条

[41] A Frozen Analogue Approach to Aminopyridinylimidazoles Leading to Novel and Promising p38 MAP Kinase Inhibitors
Selig, Roland
Goettert, Marcia
Schattel, Verena
Schollmeyer, Dieter
Albrech, Wolfgang
Laufer, Stefan
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (19) : 8429 - 8439
[42] Pharmacophore modeling of diverse classes of p38 MAP kinase inhibitors
Sarma, Rituparna
Sinha, Sharat
Ravikumar, Muttineni
Kumar, Madala Kishore
Mahmood, S. K.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (12) : 2870 - 2876
[43] EO1606 - a p38 MAP kinase inhibitor as a potential treatment of acne
Skak-Nielsen, T
Petersen, TK
Fullerton, A
Aaes, H
Fjording, M
Hansen, JR
Ottosen, ER
Madsen, MW
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (02)
[44] Process Research and Development for Heterocyclic p38 MAP Kinase Inhibitors
Thiel, Oliver R.
Achmatowicz, Michal
Milburn, Robert M.
SYNLETT, 2012, (11) : 1564 - 1574
[45] 'Reverse' α-ketoamide-based p38 MAP kinase inhibitors
Montalban, Antonio Garrido
Boman, Erik
Chang, Chau-Dung
Ceide, Susana Conde
Dahl, Russell
Dalesandro, David
Delaet, Nancy G. J.
Erb, Eric
Gibbs, Andrew
Kahl, Jeff
Kessler, Linda
Lundstroem, Jan
Miller, Stephen
Nakanishi, Hiroshi
Roberts, Ed
Saiah, Eddine
Sullivan, Robert
Wang, Zhijun
Larson, Christopher J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (20) : 5456 - 5459
[46] Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase
Tamayo, N
Liao, L
Goldberg, M
Powers, D
Tudor, YY
Yu, V
Wong, LM
Henkle, B
Middleton, S
Syed, R
Harvey, T
Jang, G
Hungate, R
Dominguez, C
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (09) : 2409 - 2413
[47] Discovery and design of benzimidazolone based inhibitors of p38 MAP kinase
Hammach, Abdelhakim
Barbosa, Antonio
Gaenzler, Faith Corbo
Fadra, Tazmeen
Goldberg, Daniel
Hao, Ming-Hong
Kroe, Rachel R.
Liu, Pingrong
Qian, Kevin C.
Ralph, Mark
Sarko, Christopher
Soleymanzadeh, Fariba
Moss, Nell
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (24) : 6316 - 6320
[48] Allosteric and slow binding inhibitors of p38 MAP kinase.
Regan, J
Breitfelder, S
Cirillo, P
Gilmore, T
Graham, A
Hickey, E
Madwed, J
Moriak, M
Moss, N
Pargellis, C
Proto, A
Tong, L
Torcellini, C
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U683 - U683
[49] The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase
Wilson, KP
McCaffrey, PG
Hsiao, K
Pazhanisamy, S
Galullo, V
Bemis, GW
Fitzgibbon, MJ
Garon, PR
Murcko, MA
Su, MSS
CHEMISTRY & BIOLOGY, 1997, 4 (06): : 423 - 431
[50] p38 MAP kinase inhibitors: Many are made, but few are chosen
Dominguez, C
Powers, DA
Tamayo, N
CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2005, 8 (04) : 421 - 430

← 1 2 3 4 5 →